Astera Labs, Saratoga Investment, Kezar Life Sciences and more via Investing.com

Stock moves by schedule:

Kezar Life Sciences (NASDAQ: ) rose 24% after Concentra Biosciences offered to acquire the company for $1.10 per share in cash, plus a contingent value right (“CVR”) that represents the right to receive 80% of net proceeds from any license or disposition of Kezar’s development programs or intellectual property.

Saratoga Investment (NYSE: ) rose 10% after reporting stronger-than-expected quarterly EPS.

Delek Logistics (NYSE:) Partners, LP (DKL) fell 9% after announcing an underwritten public offering of $150,000,000 of common units representing limited partnership interests.

Crinetics Pharmaceuticals (NASDAQ: ) fell 1.4% after announcing that it intends to offer and sell, subject to market and other conditions, $400.0 million of its common stock in a proposed underwritten public offering.

Astera Labs (ALAB) rose 3% after announcing a new portfolio of fabric switches, including the industry’s first PCIe 6 switch, built from the ground up for demanding AI workloads in accelerated computing platforms deployed at cloud scale.